Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial

By sjmartinez • July 18, 2023

Belperio J, Nguyen T, Lombardi DA, Bogus M, Moskalenko V, Singh D, Haumann B, Bourdet DL, Kaufman E, Pfeifer ND, Thompson CG, Woo J, Moran EJ, Saggar R. Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial. BMJ Open Respir Res. 2023 Jul;10(1):e001627. doi: 10.1136/bmjresp-2023-001627. PMID: 37460276.

Tags: covid-19, Nebuliser therapy, Publications, Pulmonary, Critical Care & Sleep Medicine

Coronary Artery Calcium for Risk Stratification of Heart Failure Mortality: The Coronary Artery Calcium Consortium

Mhaimeed O, Dardari ZA, Khorsandi M, Dzaye O, Sharma K, Nasir K, Berman DS, Budoff MJ, Shaw LJ, Rumberger JA, Miedema MD, Blaha MJ. Coronary[...]

The relation of heavy or prolonged bleeding during the menopause transition to risk of hysterectomy

Harlow SD, Hood MM, Mukwege A, Randolph JF Jr, Gold EB, Elliott MR, White AC, Greendale GA. The relation of heavy or prolonged bleeding during[...]

Oxygen dissociation curve inflection point during incremental exercise: a trigger for the Bohr effect

Burchert HH, Stringer WW, Dash RK. Oxygen dissociation curve inflection point during incremental exercise: a trigger for the Bohr effect. Pflugers Arch. 2025 Jul 10.[...]